IL10 and systemic lupus erythematosus: Systemic IL-10 blockade bears a significant risk of adverse autoimmune reactions, which makes any such approach problematic, although interestingly, a small study administering neutralizing IL-10-specific antibodies to six systemic lupus erythematosus patients showed that this was surprisingly well tolerated [31].